Skip to main content
Download PDF
Download ePub

Correction to: SGLT2 inhibitors: a novel choice for the combination therapy in diabetic kidney disease

Cardiovascular Diabetology volume 17, Article number: 38 (2018) Cite this article

The Original Article was published on 16 May 2017

Correction to: Cardiovasc Diabetol (2017) 16:65 https://doi.org/10.1186/s12933-017-0547-1

Following publication of the original article [1] the authors reported that the first affiliation (“Medical Center of the Graduate School, Nanchang University, China”) had been added in error, and that the correct author information is as given in this erratum.

Reference

  1. Zou H, Zhou B, Gaosi X. SGLT2 inhibitors: a novel choice for the combination therapy in diabetic kidney disease. Cardiovasc Diabetol. 2017;16:65. https://doi.org/10.1186/s12933-017-0547-1.

    Article  PubMed  PubMed Central  Google Scholar 

Download references

Publisher’s Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Author information

Author notes

  1. Honghong Zou and Baoqin Zhou contributed equally to this work

Authors and Affiliations

  1. Department of Nephrology, The Second Affiliated Hospital of Nanchang University, No. 1, Minde Road, Donghu District, Nanchang, Zip Code: 330006, People’s Republic of China

    Honghong Zou, Baoqin Zhou & Gaosi Xu

Authors
  1. Honghong Zou
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Baoqin Zhou
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Gaosi Xu
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Gaosi Xu.

Additional information

The original article can be found online at https://doi.org/10.1186/s12933-017-0547-1.

Rights and permissions

Open Access This article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Zou, H., Zhou, B. & Xu, G. Correction to: SGLT2 inhibitors: a novel choice for the combination therapy in diabetic kidney disease. Cardiovasc Diabetol 17, 38 (2018). https://doi.org/10.1186/s12933-018-0676-1

Download citation

  • Received:

  • Accepted:

  • Published:

  • DOI: https://doi.org/10.1186/s12933-018-0676-1

Cardiovascular Diabetology

ISSN: 1475-2840